SPRY icon

ARS Pharmaceuticals

70 hedge funds and large institutions have $94.7M invested in ARS Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 28 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
-2
Holders Change %
-2.78%
% of All Funds
1.11%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
14
Increased
21
Reduced
28
Closed
16
Calls
$188K
Puts
$3K
Net Calls
+$185K
Net Calls Change
-$221K
Name Holding Trade Value Shares
Change
Shares
Change %
TI
76
Trexquant Investment
Connecticut
-$203K -30,498 Closed
HS
77
HighVista Strategies
Massachusetts
-$149K -22,434 Closed
VF
78
Virtu Financial
New York
-$135K -20,317 Closed
ECM
79
ExodusPoint Capital Management
New York
-$128K -19,148 Closed
PP
80
PDT Partners
New York
-$112K -16,881 Closed
BOTOTLSJU
81
Board of Trustees of The Leland Stanford Junior University
California
-$97K -14,515 Closed
SG Americas Securities
82
SG Americas Securities
New York
-$76K -11,405 Closed
ECM
83
EMC Capital Management
Texas
-$48K -7,224 Closed
EBA
84
Eagle Bay Advisors
New York
-$42K -5,930 Closed
US Bancorp
85
US Bancorp
Minnesota
-$12K -1,843 Closed